Jueun Park

Jueun Park

Auto-generated profile, based on publicly available information

Jueun Park

Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Asian Journal of Surgery
Verified
Journal Article
Open access
JPJueun Park
Jueun Park
HBHyungJoo Baik
HyungJoo Baik
SKSang Hyun Kang
Sang Hyun Kang
SSSang Hyuk Seo
Sang Hyuk Seo
KKKwang Hee Kim
Kwang Hee Kim
MAMin Sung An
Min Sung An
45% of colon cancer patients are elderly, yet they are often deviated from standard cancer management. The MOSAIC trial favored FOLFOX over FL with superior oncologic outcomes; however, which regimen is most beneficial in elderly population remains unclear. This study aimed to compare the efficacy of oxaliplatin-added chemotherapy and capecitabine monotherapy in high-risk stage II/stage III elderly colon cancer patients. Colon cancer patients ≥70 years of age who received adjuvant chemotherapy at Inje University Busan Paik Hospital between February 2009 to April 2016 were included. Patients were separated into the oxaliplatin-added group and capecitabine monotherapy group. The primary outcomes were CSS and OS. Of 74 patients, 45 received oxaliplatin-added chemotherapy and 29 received capecitabine monotherapy. There was no difference between the two groups in CSS or OS (p = 0.9670 and p = 0.6801, respectively). The N stage was significantly associated with CSS in both uni/multivariate analysis (p = 0.0565 and p = 0.0347, respectively). The oxaliplatin-added group had more stage III patients, so we performed a subgroup analysis of CSS and OS based on stage, which also showed no significant difference. Capecitabine monotherapy is an oncologically safe regimen compared to oxaliplatin-added regimens in elderly patients with high-risk stage II/stage III colon cancer.

1 January 2023 in Annals of Surgical Treatment and Research
Verified
Journal Article
Open access
PDF file
SGSujin Gang
Sujin Gang
HKHyunhee Kwon
Hyunhee Kwon
JPJueun Park
Jueun Park
DKDae Yeon Kim
Dae Yeon Kim
Gang S, et al. Ann Surg Treat Res. 2023 Dec;105(6):396-403. https://doi.org/10.4174/astr.2023.105.6.396

1 November 2023 in Korean Journal of Transplantation
Verified
Journal Article
Open access
PDF file
JNJung-Man Namgoong
Jung-Man Namgoong
SHShin Hwang
Shin Hwang
GPGil-Chun Park
Gil-Chun Park
HKHyunhee Kwon
Hyunhee Kwon
SGSujin Gang
Sujin Gang
SOSeak Hee Oh
Seak Hee Oh
Jung-Man Namgoong, Shin Hwang, Gil-Chun Park, Hyunhee Kwon, Sujin Gang, Jueun Park, Kyung Mo Kim, Seak Hee Oh. Korean J Transplant 2023;37:260-8. https://doi.org/10.4285/kjt.23.0037

25 November 2022 in Annals of Liver Transplantation
Verified
Journal Article
Open access
PDF file
JNJung-Man Namgoong
Jung-Man Namgoong
SHShin Hwang
Shin Hwang
GPGil-Chun Park
Gil-Chun Park
SHSuhyeon Ha
Suhyeon Ha
SGSujin Gang
Sujin Gang
SOSeak Hee Oh
Seak Hee Oh
Jung-Man Namgoong, Shin Hwang, Gil-Chun Park, Suhyeon Ha, Sujin Gang, Jueun Park, Seak Hee Oh. Ann Liver Transplant -0001;0:. https://doi.org/10.52604/alt.22.0019

13 January 2025 in Annals of Liver Transplantation
Verified
Journal Article
Open access
PDF file
JNJung-Man Namgoong
Jung-Man Namgoong
SHShin Hwang
Shin Hwang
GPGil-Chun Park
Gil-Chun Park
HKHyunhee Kwon
Hyunhee Kwon
SHSuhyeon Ha
Suhyeon Ha
SOSeak Hee Oh
Seak Hee Oh
Jung-Man Namgoong, Shin Hwang, Gil-Chun Park, Hyunhee Kwon, Suhyeon Ha, Sujin Gang, Jueun Park, Kyung Mo Kim, Seak Hee Oh. Ann Liver Transplant -0001;0:. https://doi.org/10.52604/alt.24.0024

1 January 2025 in Annals of Surgical Treatment and Research
Verified
Journal Article
Open access
PDF file
SHSuhyeon Ha
Suhyeon Ha
SGSujin Gang
Sujin Gang
JPJueun Park
Jueun Park
HKHyunhee Kwon
Hyunhee Kwon
DKDae Yeon Kim
Dae Yeon Kim
JNJung-Man Namgoong
Jung-Man Namgoong
Ha S, et al. Ann Surg Treat Res. 2025 Feb;108(2):93-97. https://doi.org/10.4174/astr.2025.108.2.93